http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : ( Shun-wen Hsiao ) (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
( Shun-wen Hsiao ),( Hsu-heng Yen ),( Yang-yuan Chen ) 대한소화기학회 2022 Gut and Liver Vol.16 No.6
The association between inflammatory bowel disease and colorectal cancer is well known. Al though the overall incidence of inflammatory bowel disease has declined recently, patients with this disease still have a 1.7-fold increased risk of colorectal cancer. The risk factors for develop ing colorectal cancer include extensive colitis, young age at diagnosis, disease duration, primary sclerosing cholangitis, chronic colonic mucosal inflammation, dysplasia lesion, and post-inflam matory polyps. In patients with inflammatory bowel disease, control of chronic inflammation and surveillance colonoscopies are important for the prevention of colorectal cancer. The 2017 guide lines from the European Crohn’s and Colitis Organisation suggest that colonoscopies to screen for colorectal cancer should be performed when inflammatory bowel disease symptoms have lasted for 8 years. Current evidence supports the use of chemoprevention therapy with mesala mine to reduce the risk of colorectal cancer in patients with ulcerative colitis. Other compounds, including thiopurine, folic acid, statin, and tumor necrosis factor-α inhibitor, are controversial. Large surveillance cohort studies with longer follow-up duration are needed to evaluate the im pact of drugs on colorectal cancer risks. (Gut Liver 2022;16:840-848)
KISS연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
